键凯科技：注射用聚乙二醇伊立替康新适应症II期临床试验获批

array(1) { [375833]=> array(2) { [2]=> array(3) { [0]=> string(12) "临床试验" [1]=> string(12) "键凯科技" [2]=> string(12) "聚乙二醇" } [4]=> array(1) { [0]=> string(19) "同花顺7x24快讯" } } }